GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,778.00p
   
  • Change Today:
    -10.50p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,316.00p
  • Currency: UK Pounds
  • Shares Issued: 4,144.92m
  • Volume: 6,820,641
  • Market Cap: £73,697m
  • RiskGrade: 129

Latest ShareCast News

GSK reports promising results from asthma treatment trials

By Josh White

Date: Tuesday 21 May 2024

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

London close: Stocks recoup some earlier losses

By Josh White

Date: Friday 17 May 2024

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

GSK raises £1.25bn from sale of remaining Haleon stake

By Michele Maatouk

Date: Friday 17 May 2024

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

London close: Stocks mixed as ex-divs drag on FTSE 16-May-2024 ShareCast
GSK to sell remaining 4.2% stake in Haleon 16-May-2024 ShareCast
London close: Stocks fall ahead of US Fed decision 01-May-2024 ShareCast
GSK lifts annual guidance on strong virus treatm... 01-May-2024 ShareCast
GSK's endometrial cancer drug receives FDA appro... 24-Apr-2024 ShareCast
GSK posts promising results from gonorrhoea trea... 17-Apr-2024 ShareCast
GSK meningococcal vaccine accepted by US FDA for... 16-Apr-2024 ShareCast
GSK unveils promising results from endometrial c... 18-Mar-2024 ShareCast
GSK reports more encouraging trial results for B... 07-Mar-2024 ShareCast
GSK's ViiV upbeat on ultra-long-acting HIV treat... 05-Mar-2024 ShareCast
GSK reaches settlement in another Zantac case 29-Feb-2024 ShareCast
GSK reports positive results from gonorrhoea tre... 26-Feb-2024 ShareCast
GSK's ViiV sees success in latest HIV treatment ... 21-Feb-2024 ShareCast
Berenberg hikes target price on GSK 15-Feb-2024 ShareCast
London close: Stocks fall as US inflation tops e... 13-Feb-2024 ShareCast
London close: Stocks fall as US inflation tops e... 13-Feb-2024 ShareCast
Citi ups recommendation on GSK to 'buy' 13-Feb-2024 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,778.00p
Change Today -10.50p
% Change -0.59 %
52 Week High 1,812.50p
52 Week Low 1,316.00p
Volume 6,820,641
Shares Issued 4,144.92m
Market Cap £73,697m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.03% below the market average60.03% below the market average60.03% below the market average60.03% below the market average60.03% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average
Price Trend
49.74% above the market average49.74% above the market average49.74% above the market average49.74% above the market average49.74% above the market average
59.26% above the sector average59.26% above the sector average59.26% above the sector average59.26% above the sector average59.26% above the sector average
Income
9.60% above the market average9.60% above the market average9.60% above the market average9.60% above the market average9.60% above the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
20.51% below the market average20.51% below the market average20.51% below the market average20.51% below the market average20.51% below the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 23-May-2024

Time Volume / Share Price
16:28 0 @ 1,773.50p
16:28 0 @ 1,773.50p
17:14 254,112 @ 1,787.68p
16:00 2 @ 1,775.00p
15:50 0 @ 1,778.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page